Published May 2019
| Version v1
Journal article
SABR in High-Risk Prostate Cancer: Outcomes From 2 Prospective Clinical Trials With and Without Elective Nodal Irradiation
Creators
- 1. Division of Radiation Oncology, College of Medicine, King Saud University, Riyadh (Saudi Arabia)
- 2. Department of Radiation Oncology, University of Toronto, Toronto (Canada)
- 3. Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto (Canada)
Description
There is limited data on stereotactic ablative radiation therapy (SABR) in high-risk prostate cancer (PCa), especially regarding the role of elective nodal irradiation (ENI). This study compares 2 prospective phase 2 trials using SABR in high-risk PCa, with and without ENI.
Additional details
Identifiers
- DOI
- 10.1016/j.ijrobp.2018.11.011;
- PII
- S036030161833997X;
Publishing Information
- Journal Title
- International Journal of Radiation Oncology, Biology and Physics
- Journal Volume
- 104
- Journal Issue
- 1
- Journal Page Range
- p. 36-41
- ISSN
- 0360-3016
- CODEN
- IOBPD3
INIS
- Country of Publication
- United States
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 55057224
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- CLINICAL TRIALS; COMPARATIVE EVALUATIONS; HEALTH HAZARDS; IRRADIATION; NEOPLASMS; PROSTATE; RADIOTHERAPY
- Descriptors DEC
- BODY; DISEASES; EVALUATION; GLANDS; HAZARDS; MALE GENITALS; MEDICINE; NUCLEAR MEDICINE; ORGANS; RADIOLOGY; TESTING; THERAPY
Optional Information
- Copyright
- Copyright (c) 2018 Elsevier Inc. All rights reserved.